Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23
Price to sales ratio
4.83
Dividends per share
9.66
Dividend yield %
2.95

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
42
MRK
Merck & Company, Inc. Common Stock
123.66 USD+0.09%-2.34%+1.78%+48.24%305.42 B USD
44
NVS
Novartis AG
153.53 USD-0.34%-1.32%-0.31%+27.51%292.96 B USD
92
GILD
Gilead Sciences, Inc. - Common Stock
130.81 USD+0.75%+1.21%+3.40%+19.17%162.41 B USD
109
PFE
Pfizer, Inc. Common Stock
24.45 USD+1.07%+2.64%-7.00%-4.42%139.35 B USD

Frequently asked questions about Amgen Inc. - Common Stock

What is the Amgen Inc. - Common Stock stock price today?

The current price of Amgen Inc. - Common Stock (AMGN) is 359.71. Over the past 24 hours, the stock has changed by -1.01%. Follow the AMGN chart for real-time price dynamics.

What is the stock ticker of Amgen Inc. - Common Stock?

Amgen Inc. - Common Stock trades under the ticker AMGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Amgen Inc. - Common Stock stock going up?

AMGN has changed by -1.97% over the last week, +1.98% over the last month, and +22.41% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Amgen Inc. - Common Stock release financial reports?

Yes. You can track Amgen Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Amgen Inc. - Common Stock net income for the last quarter?

Amgen Inc. - Common Stock reported net income of 1.82 B for the last quarter. The previous quarter showed 1.33 B, which means net income changed by +36.46%.

How many employees does Amgen Inc. - Common Stock have?

As of the latest available data, Amgen Inc. - Common Stock has 31.5 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Amgen Inc. - Common Stock EBITDA?

Amgen Inc. - Common Stock EBITDA is 3.78 B, and its EBITDA margin is 43.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Amgen Inc. - Common Stock stock?

You can buy Amgen Inc. - Common Stock (AMGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Amgen Inc. - Common Stock stock?

Investing in Amgen Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AMGN chart and related analysis on metatrader.com as part of your research.

Amgen Inc. - Common Stock

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000.

News